Shrestha, Rupendra. “Induced Pluripotent Stem Cells Are Japanese Brand Sources for Therapeutic Cells to Pretrial Clinical Research”. Progress in Stem Cell 7, no. 1 (June 8, 2020): 296-303. Accessed October 30, 2020. http://www.cellstemcell.org/index.php/PSC/article/view/409.